115 related articles for article (PubMed ID: 17892946)
1. Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells.
Nishiyama K; Sugawara K; Nouchi T; Kawano N; Soejima K; Abe S; Mizokami H
Biologicals; 2008 Mar; 36(2):122-33. PubMed ID: 17892946
[TBL] [Abstract][Full Text] [Related]
2. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
3. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
Idoji Y; Watanabe Y; Yamashita A; Yamanishi K; Nishiguchi S; Shimada K; Yasunaga T; Yamanishi H
Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
[TBL] [Abstract][Full Text] [Related]
4. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
5. A double WAP domain (DWD)-containing protein with proteinase inhibitory activity in Chinese white shrimp, Fenneropenaeus chinensis.
Du ZQ; Ren Q; Zhao XF; Wang JX
Comp Biochem Physiol B Biochem Mol Biol; 2009 Oct; 154(2):203-10. PubMed ID: 19545640
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines.
van Wielink R; Kant-Eenbergen HC; Harmsen MM; Martens DE; Wijffels RH; Coco-Martin JM
J Virol Methods; 2011 Jan; 171(1):53-60. PubMed ID: 20933017
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a persistent respiratory syncytial virus showing a low-fusogenic activity associated to an impaired F protein.
Sarmiento RE; Arias CF; Méndez E; Gómez B
Virus Res; 2009 Jan; 139(1):39-47. PubMed ID: 19014983
[TBL] [Abstract][Full Text] [Related]
9. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
10. [Cloning and expression of canine interferon-gamma gene in mouse SP2/0 cell line].
Yang Q; Xia C; Zhao DM; Wang M
Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):365-8. PubMed ID: 12192876
[TBL] [Abstract][Full Text] [Related]
11. High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
Smith KA; Colvin CJ; Weber PS; Spatz SJ; Coussens PM
Vaccine; 2008 Jul; 26(29-30):3778-82. PubMed ID: 18524432
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1.
Hammond JR; Stolk M; Archer RG; McConnell K
Eur J Pharmacol; 2004 Apr; 491(1):9-19. PubMed ID: 15102528
[TBL] [Abstract][Full Text] [Related]
13. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
[TBL] [Abstract][Full Text] [Related]
14. Factors responsible for plaque formation of A/duck/Siberia/272/1998 (H13N6) influenza virus on MDCK cells.
Tsuda Y; Isoda N; Sakoda Y; Kida H
Virus Res; 2009 Mar; 140(1-2):194-8. PubMed ID: 19146891
[TBL] [Abstract][Full Text] [Related]
15. Maturation efficiency of viral glycoproteins in the ER impacts the production of influenza A virus.
Ueda M; Yamate M; Du A; Daidoji T; Okuno Y; Ikuta K; Nakaya T
Virus Res; 2008 Sep; 136(1-2):91-7. PubMed ID: 18550190
[TBL] [Abstract][Full Text] [Related]
16. Use of MDCK cells for production of live attenuated influenza vaccine.
Liu J; Shi X; Schwartz R; Kemble G
Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
[TBL] [Abstract][Full Text] [Related]
17. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
18. The growth of attenuated influenza vaccine donor strains in continuous cell lines.
Audsley JM; Tannock GA
J Virol Methods; 2005 Feb; 123(2):187-93. PubMed ID: 15620401
[TBL] [Abstract][Full Text] [Related]
19. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
Genzel Y; Olmer RM; Schäfer B; Reichl U
Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
[TBL] [Abstract][Full Text] [Related]
20. Proteinase inhibitors from Streptomyces with antiviral activity.
Serkedjieva J; Angelova L; Remichkova M; Ivanova I
J Basic Microbiol; 2006; 46(6):504-12. PubMed ID: 17139614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
